Literature DB >> 8468106

Hypnotic susceptibility and the endogenous eyeblink: a brief communication.

S Lindsay1, R M Kurtz, J A Stern.   

Abstract

This study investigated the relationship between hypnotic susceptibility, hypnotic state, and the endogenous eyeblink with 36 undergraduates, who were assigned to four independent groups (waking-low, hypnotized-low, waking-high, and hypnotized-high susceptibles) on the basis of combined cutoff scores on both the Creative Imagination Scale and the Stanford Hypnotic Clinical Scale for Adults. The auditory vigilance task required subjects to discriminate between 200 ms and 300 ms tones over a 35-minute period. Hypnotic depth was controlled across trials using the Long Stanford Scale of Hypnotic Depth. As predicted, high-susceptible subjects had a significantly lower blink rate than low-susceptible subjects. The predicted interaction between susceptibility and hypnotic state was also confirmed. High-susceptible subjects showed a significant decrease in blinking for the hypnotized condition, whereas low-susceptible subjects did not. The need for replication with more adequate measures of susceptibility is discussed.

Entities:  

Mesh:

Year:  1993        PMID: 8468106     DOI: 10.1080/00207149308414540

Source DB:  PubMed          Journal:  Int J Clin Exp Hypn        ISSN: 0020-7144


  3 in total

1.  Revisiting the association between hypnotisability and blink rate.

Authors:  Francesco Di Gruttola; Paolo Orsini; Maria C Carboncini; Bruno Rossi; Enrica L Santarcangelo
Journal:  Exp Brain Res       Date:  2014-08-20       Impact factor: 1.972

2.  The existence of a hypnotic state revealed by eye movements.

Authors:  Sakari Kallio; Jukka Hyönä; Antti Revonsuo; Pilleriin Sikka; Lauri Nummenmaa
Journal:  PLoS One       Date:  2011-10-24       Impact factor: 3.240

3.  The "hypnotic state" and eye movements: Less there than meets the eye?

Authors:  Etzel Cardeña; Barbara Nordhjem; David Marcusson-Clavertz; Kenneth Holmqvist
Journal:  PLoS One       Date:  2017-08-28       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.